Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 80524900080

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80524900080 and manufactured by manufacturer not specified. The registration is held by BIO ADVANCE DIAGNOSTICOS LTDA with validity until Aug 15, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80524900080
2 Related Devices
Registration Details
ANVISA Registration Number: 80524900080
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Registration Details

80524900080

25351052645202292

09593438000103

Company Information

Dates and Status

Aug 15, 2022

15/08/2032

09/18/2025 19:00:01

Registration Details

80524900080

25351052645202292

09593438000103

Company Information

CTK BIOTECH, INC.
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Aug 15, 2022

15/08/2032

09/18/2025 19:00:01